Homophilic PECAM-1(CD31) interactions prevent endothelial cell apoptosis but do not support cell spreading or migration

Journal of Cell Science

Volumn 112, Issue 12, 1999, Pages 1989-1997

  Bird, Ian N ^b   Taylor, Vanessa ^a   Newton, Justin P ^a   Spragg, Julia H ^b   Simmons, David L ^a,d   Salmon, Michael ^c   Buckley, Christopher D ^c  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b Yamanouchi Research Institute   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d SmithKline Beecham Pharmaceutical ^*  (United Kingdom)

Author keywords

Adhesion; Apoptosis; CD31; Endothelium; PECAM 1; Signalling

Indexed keywords

CD31 ANTIGEN; FIBRONECTIN; INTEGRIN; PERVANADATE; PHOSPHOPROTEIN;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL SPREADING; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

ANTIGENS, CD31; APOPTOSIS; CELL ADHESION; CELL COMMUNICATION; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; PHOSPHORYLATION; PROTEIN BINDING; RECEPTORS, VITRONECTIN;

EID: 0032806934     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Almendro, N., Bellon, T., Ruis, C., Lastres, P., Langa, C., Corbi, A. and Bernabeu, C. (1996). Cloning of the human platelet endothelial cell adhesion molecule-1 promoter and its tissue specific expression. J. Immunol. 157, 5411-5421.
2. Bird, I. N., Spragg, J. H., Ager, A. and Matthews, N. (1993). Studies of lymphocyte transendothelial migration: analysis of migrated cell phenotypes with regard to CD31 (PECAM-1), CD45RA and CD45RO. Immunology 80, 553-560.
3. Bischoff, J. (1997). Cell adhesion and angiogenesis. J. Clin. Invest. 99, 373-376.
4. Brooks, P. C., Clark, R. A. F. and Cheresh, D. A. (1994a). Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science 264, 569-571.
5. Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G. and Cheresh, D. A. (1994b). Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157-1164.
6. Brown, E. J. (1997). Adhesive interactions in the immune system. Trends Cell Biol. 7, 289-295.
7. Buckley, C. D., Doyonnas, R., Newton, J. P., Blystone, S. D., Brown, E. J., Watt. S. M. and Simmons, D. L. (1996). Identification of αvβ3 as a heterotypic ligand for CD31/PECAM-1. J. Cell Sci. 109, 437-445.
8. Bussolino, F., Mantovani, A. and Persico, G. (1997). Molecular mechanisms of blood vessel formation. Trends Biochem. Sci. 22, 251-256.
9. Cao, M. Y., Huber, M., Beauchemin, N., Famiglietti, J., Albelda, S. M. and Veillette, A. (1998). Regulation of mouse PECAM-1 tyrosine phosphorylation by the Src and Csk families of protein-tyrosine kinases. J. Biol. Chem. 273, 15765-15772.
10. Chen, W., Knapp, W., Majdic, O., Stockinger, H., Bohmig, G. A. and Zlabinger, G. J. (1994). Co-ligation of CD31 and FcγRII induces cytokine production in human monocytes. J. Immunol. 152, 3991-3997.
11. DeLisser, H. M., Yan, C. Y., Newman, P. J., Muller, W. A., Buck, C. A. and Albelda, S. M. (1993). PECAM-1 (CD31)-mediated cellular aggregation involves cell surface glycosaminoglycans. J. Biol. Chem. 268, 16037-16046.
12. Drake, C. J., Cheresh, D. A. and Little, C. D. (1995). An antagonist of integrin alpha v beta 3 prevents maturation of blood vessels during embryonic neovascularization. J. Cell Sci. 108, 2655-2661.
13. Famiglietti, J., Sun, J., DeLisser, H. M. and Albelda, S. M. (1997). Tyrosine residue in exon 14 of the cytoplasmic domain of platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) regulates ligand binding specificity. J. Cell Biol. 138, 1425-1435.
14. Fawcett, J., Buckley, C. D., Holness, C. L., Bird, I. N., Spragg, J. H., Saunders, J., Harris, A. and Simmons, D. L. (1995). Mapping the homotypic binding sites in CD31 and the role of CD31 adhesion in the formation of interendothelial cell contacts. J. Cell Biol. 128, 1229-1241.
15. Folkman, J. (1995). Angiogenesis in cancer, vascular and rheumatoid and other disease. Nature Med. 1, 27-31.
16. Frielander, M., Theesfeld, C. L., Sugita, M., Fruttiger, M., Thomas, M. A., Chang, S. and Cheresh, D. A. (1996). Involvement of integrins alpha(v)beta(3) and alpha(v)beta(3) in ocular neovascular disease. Proc. Nat. Acad Sci. USA 93, 9764-9769.
17. Goldberger, A., Middleton, K. A., Oliver, J. A., Paddock, C., Yan, H-C., Delisser, H. M., Albelda, S. M. and Newman, P. J. (1994). Biosynthesis and processing of the cell adhesion molecule PECAM-1 includes production of a soluble form. J. Biol. Chem. 269, 17183-17191.
18. Hammes, H. P., Brownlee, M., Jonczyk, A., Sutter, A. and Preissner, K. T. (1996). Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nature Med. 2, 529-533.
19. Horenstein, A. L., Stockinger, H., Imhof, B. A. and Malavasi, F. (1998). CD38 binding to human myeloid cells is mediated by mouse and human CD31. Biochem. J. 330, 1129-1135.
20. Imhof, B. A., Weerasinghe, D., Brown, E. J., Lindberg, F. P., Hammel, P., Piali, L., Dessing, M. and Gisler, R. (1998). Cross talk between αvβ3 and α4β1 integrins regulates lymphocyte migration on vascular cell adhesion molecule 1 Eur. J. Immunol. 27, 3242-3252.
21. Ioffreda, M. D., Albelda, S. M., Elder, D. E., Radu, A., Leventhal, L. C., Zweiman, B. and Murphy, G. F. (1993). TNFα induces E-selectin expression and PECAM-1 (CD31) redistribution in extracutaneous tissues. Endothelium 1, 47-54.
22. Jackson, D. E, Ward, C. M., Wang, R. and Newman, P. J. (1997a). The protein-tyrosine phosphatase SHP-2 binds platelet/endothelial cell adhesion molecule-1 (PECAM-1) and forms a distinct signaling complex during platelet aggregation. J. Biol. Chem. 272, 6986-6993.
23. Jackson, D. E., Kupcho, K. R. and New man, P. J. (1997b). Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of platelet/endothelial cell adhesion molecule-1 (PECAM-1) that are required for the cellular association and activation for the protein-tyrosine phosphatase, SHP-2. J. Biol. Chem. 272, 24868-24875.
24. Kim, C. S., Wang, T. and Madri J. A. (1998). Platelet endothelial cell adhesion molecule-1 expression modulates endothelial cell migration in vivo. Lab Invest. 78, 583-590
25. Kirschbaum, N. E. and Newman, P. J. (1993). Thromb. Haemostasia 69. 1010a.
26. Kirschbaum, N. E., Gumina, R. J. and Newman, P. J. (1994). Organization of the gene for human platelet/endothelial cell adhesion molecule-1 shows alternatively spliced isoforms and a functionally complex cytoplasmic domain. Blood 84, 4028-4037.
27. Korff, T. and Augustin, H. G. (1998). Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. J. Cell Biol. 143, 1341-1352
28. Lampugnani, M. G., Resnati, M., Dejana, E. and Marchisio, P. C. (1991). The role of integrins in the maintenance of endothelial monolayer integrity. J. Cell Biol. 112, 479-490.
29. Lampugnani, M. G., Corada, M., Caveda, L., Breviario, F., Ayalon, O., Geiger, B. and Dejana, E. (1995). The molecular organization of endothelial cell to cell junctions: differential association of plakoglobin, beta-catenin, and alpha-catenin with vascular endothelial cadherin (VE-cadherin) J. Cell Biol 129 203-217.
30. Leaveslev, D. I., Schwartz, M. A., Rosenfeld, M. and Cheresh, D. A. (1993) Integrin β1-and β3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J. Cell Biol. 121, 163-170.
31. Litwin, M., Clark, K,. Noack, L., Furze, J., Berndt, M., Albelda, S. M., Vadas, M. and Gamble, J. (1997). Novel cytokine-independent induction of endothelial cell adhesion molecules regulated by platelet/endothelial cell adhesion molecule (CD31). J. Cell Biol. 139, 219-228.
32. Lu, T. T., Van, L. G. and Madri, J. A. (1996). Integrin engagement mediates tyrosine dephosphorylation on platelet-endothelial cell adhesion molecule I. Proc. Nat. Acta. Sci. USA 93, 11808-11813.
33. Lu, T. T., Barreuther, M., Davies, S. and Madri, J. A. (1997) Platelet endothelial cell adhesion molecule-1 is phosphorylalable by c-Src, binds src-src homology 2 domain, and exhibits immunoreceptor tyrosine-based activation motif-like properties. J. Biol. Chem. 272, 14442-14446.
34. Masuda, M., Osawa, M., Shigematsu, H., Harada, N. and Fujiwara, K. (1997). Platelet endothelial cell adhesion molecule-1 is a major SH-PTP-2 binding protein in vascular endothelial cells. FEBS Lett. 408, 331-336.
35. Meredith, J. E., Fazeli, B. and Schwartz, M. A. (1993). The extracellular matrix as a survival factor. Mol. Biol Cell 4, 953-961.
36. Meredith, J. E. and Schwartz, M. A. (1997). Integrins: Adhesion and apoptosis. Trends Cell Biol. 7, 146-150.
37. Muller, W. A., Berman, M. E., Newman, P. J., De Lisser, H. M. and Albelda, S. M. (1992). A heterophilic adhesion mechanism for platelet/endothelial cell adhesion molecule 1 (CD31). J. Exp. Med. 175, 1401-1404.
38. Mutin, M., Dignat-George, F. and Sampol, J. (1997). Immunologic phenotype of culture endothelial cells: quantitative analysis of cell surface molecules. Tissue Antigens 50, 449-458.
39. Newman, P. J., Berndt, M. C., Gorski, J., White, G. C., Lyman, S., Paddock, C. and Muller, W. A. (1990). PECAM-1(CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 247, 1219-1222.
40. Newman, P. J. (1997). Cell adhesion in vascular biology. The biology of PECAM-1. J. Clin. Invest. 99, 3-8.
41. Newman, P. J. (1999). Switched at birth: a new family for PECAM-1. J. Clin. Invest. 103, 5-9.
42. Newton, J. P., Buckley, C. D., Jones, E. Y. and Simmons, D. L. (1997). Residues on both faces of the first immunoglobulin fold contribute to homophilic bindings sites of PECAM-1/CD31. J. Biol. Chem. 272, 20555-20563.
43. Osawa, M., Masuda, M., Harada, N., Lopes, R. B. and Fujiwara, K. (1997). Tyrosine phosphorylation of platelet endothelial cell adhesion molecule-1(PECAM-1, CD31) in mechanically stimulated vascular endothelial cells. Eur. J. Cell Biol. 72, 229-237.
44. Piali, L., Albelda, S. M., Baldwin, H. S., Hammel, P., Gisler, R. H. and Imhof, B. A. (1993). Murine platelet endothelial cell adhesion molecule (PECAM-1)/CD31 modulates β2 integrins on lymphokine-activated killer cells. Eur. J. Immunol. 23, 2464-2471.
45. Piali, L., Hammel, P., Uherek, C., Bachmann, F., Gisler, R. H., Dunon, D. and Imhof, B. A. (1995). CD31/PECAM-1 is a ligand for αvβ3 integrin involved in adhesion of leukocytes to endothelium. J. Cell Biol. 130, 451-460.
46. Poggi, A., Panzeri, M. C., Moretta, L. and Zocchi, M. R. (1996). CD31-triggered rearrangement of the actin cytoskeleton in human natural killer cells. Eur. J. Immunol. 26, 817-824.
47. Prager, E., Sunder-Plassmann, R., Koch, C., Hotler, W., Knapp, W. and Stockinger, H. (1996). Interaction of CD31 with a heterophilic counterreceptor involved in downregulation of human T cell responses. J. Exp. Med. 184, 41-50.
48. Rainger, G. E., Buckley, C. D., Simmons, D. L. and Nash, G. B. (1999). Neutrophils sense flow generated stress and direct their migration through αvβ3-integrin. Am. J. Physiol. (in press).
49. Re, F., Zanetti, A., Sironi, M., Polentarutti, N., Lanfrancone, L., Dejana, E. and Colotta, F. (1994). Inhibition of anchorage dependent cell spreading triggers apoptosis in cultured endothelial cells. J. Cell Biol. 127, 537-546.
50. Risau, W. (1997). Mechanisms of angiogenesis. Nature 386, 671-674.
51. Romer, L. H., McLean, N. V., Van, H. C., Daise, M., Sun, J. and DeLisser, H. M. (1995). IFNγ and TNFα induce redistribution of PECAM-1 (CD31) on human endothelial cells. J. Immunol. 154, 6582-6592.
52. Sagawa, K., Swain, W., Zhang, J., Unsworth, E. and Siraganian, R. P. (1997a). Aggregation of the high affinity IgE receptor results in lhe tyrosine phosphorylation of the surface adhesion protein PECAM-1 (CD31). J. Biol. Chem. 272, 13412-13418.
53. Sagawa, K., Kimura, T., Swieter, M. and Siraganian, R. P. (1997b). The protein-tyrosine phosphatase SHP-2 associates with lyrosine-phosphorylated adhesion molecule PECAM-1 (CD31). J Biol. Chem. 272, 31086-31091.
54. Sage, E. H. (1997). Pieces of eight: bioactive fragments of extracellular proteins as regulators of angiogenesis. Trends Cell Biol. 7, 182-186.
55. Saunders, J., Bird, I. N., deBelin, J., Buckley, C. D., Newton, J. P., Simmons, D. L. and Spragg, J. H. (1995). Studies of CD31 function on human umbilical vein endothelial cells (HUVEC) during tube formation on matrigel. Inflammation Res. 44, S245.
56. Scatena, M., Almeida, M., Chaisson, M. L., Fausto, N., Nicosia, R. F. and Giachelli, C. M. (1998). NF-κB mediates αvβ3 integrin-induced endothelial cell survival. J. Cell Biol. 141, 1083-1093.
57. Shattil, S. J. and Ginsberg, M. H. (1997). Integrin signaling in vascular biology. J. Clin. Invest. 100, 1-5.
58. Sheibani, N., Newman, P. J. and Frazier, W. A. (1997). Thrombospondin-1. a natural inhibitor of angiogenesis regulates platelet-endothelial cell adhesion molecule-1 expression and endothelial cell morphogenesis. Mol. Biol. Cell 8, 1329-1341.
59. Simmons, D. L., Walker, C., Power, C. and Pigolt, R. (1990). Molecular cloning of CD31, a putative intercellular adhesion molecule closely related to carcinoembryonic antigen. J. Exp. Med. 171, 2147-2152.
60. Stromblad, S. and Cheresh, D. A. (1996). Cell adhesion and angiogenesis. Trends Cell Biol. 6, 462-468.
61. Stromblad, S., Becker, J. C., Yebra, M., Brooks, P. C. and Cheresh, D. A. (1996). Supression of p53 activity and p21WAFI/CIP1 expression by vascular cell integrin alphavbeta3 during angiogenesis. J. Clin. Invest. 98, 426-433.
62. Sun, J., Williams, J., Yan, H.-C., Amin K. M., Albelda, S. M. and DeLisser, H. M. (1996). Platelet endothelial cell adhesion molecule-1 (PECAM-1) is mediated by immunoglobulin-like domains 1 and 2 and depends on the cytoplasmic tail and the level of surface expression. J. Biol. Chem. 271, 18561-18570.
63. Sun, Q. H., DeLisser, H. M., Zukowski, M. M., Paddock, C., Albelda, S. M. and Newman, P. J. (1996). Individually distinct Ig homology domains in PECAM-1 regulate homophilic binding and modulate receptor affinity. J. Biol. Chem. 271, 11090-11098.
64. Tanaka, Y., Albelda, S. M., Morgan, K. J., van Seventer, G. A., Shimuzu, Y., Newman, P. J., Buck, C. A. and Shaw, S. (1992). CD31 expressed on distinctive T Cell subsets is a preferential amplifier of β1 integrin-mediated adhesion. J. Exp. Med. 176, 245-253.
65. Varon, D., Jackson, D. E., Shenkman, B., Dardik, R., Tamarin, I. Savion, N. and Newman, P. J. (1998). Platelet/endothelial cell adhesion molecule-I serves as a costimulatory agonist receptor that modulates integrin-dependent adhesion and aggregation of human platelets. Blood 91. 500-507.
66. Yang, C., Chang, J., Gorospe, M. and Passaniti, A. (1996). Protein tyrosine phosphatase regulation of endothelial cell apoptosis and differentiation Cell Growth Differ. 7 161-171.
67. Zehnder, J. L., Hirai, K., Shatsky, M., McGregor, J. L., Levitt, L. J. and Leung, L. L. K. (1992). The cell adhesion molecule CD31 is phosphorylated after cell activation. J. Biol. Chem. 267, 5243-5249.